Search

Search Constraints

You searched for: Author/Creator Rotolo, Federico

Search Results

1. IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial. Issue 8 (August 2019)

2. Lacutamab in patients (pts) with advanced mycosis fungoides (MF) according to KIR3DL2 expression: early results from the TELLOMAK phase 2 trial. (October 2021)

5. Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])*. Issue 12 (10th October 2022)

10. Predictive classifier for intensive treatment of head and neck cancer. Issue 24 (5th October 2020)